Skip to main content
. 2019 Oct 28;16(11):852–859. doi: 10.30773/pi.2019.0120

Table 2.

Clinical characteristics and motor subtypes of the 95 patients with delirium

Variable Hyperactive (N=34) Hypoactive (N=25) Mixed (N=30) No subtype (N=6) p
Sex (male), N (%) 22 (64.7) 14 (56.0) 18 (60.0) 1 (16.7) 0.16
Age (years), mean±SD 78.76±5.50 76.76±8.78 77.36±7.39 75.33±9.29 0.90
BUN (mg/dL), mean±SD 16.04±5.23 17.96±5.89 21.05±8.53 18.07±6.89 0.03
Number of medications received, mean±SD 5.20±2.70 6.08±3.39 5.96±3.27 7.33±3.61 0.33
Comorbid cognitive impairment, N (%) 5 (14.7) 3 (12.0) 7 (23.3) 2 (33.3) 0.21
History of delirium, N (%) 4 (11.8) 2 (8.0) 6 (20.0) 0 (0.0) 0.87
Lesion, side
Left hemisphere, N (%) 8 (23.5) 7 (28.0) 11 (36.7) 3 (50.0)
Right hemisphere, N (%) 18 (52.9) 13 (52.0) 13 (43.3) 3 (50.0) 0.13
Both hemisphere, N (%) 8 (23.5) 5 (20.0) 6 (20.0) 0 (0.0)
NIHSS score on admission, mean±SD 3.97±3.42 6.72±4.75 6.53±5.10 2.50±1.87 0.02
mRS score on admission, mean±SD 2.44±1.52 3.96±1.24 3.33±1.29 2.33±1.03 <0.01

SD: standard deviation, BUN: blood urea nitrogen, NIHSS: National Institutes of Health Stroke Scale, mRS: modified Rankin Scale